Patents by Inventor Carmen Elena ARIAS RIVAS

Carmen Elena ARIAS RIVAS has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9765036
    Abstract: The invention relates to the synthesis of a therapeutic agent which is effective against American trypanosomiasis (Chagas disease) caused by the protozoa Tripanosoma cruzi and transmitted by blood-sucking insects of the genera Triatoma or Rhodnius. This synthesis method is carried out in one step, in a solid state. It is a clean, simple, economical, rapid, easily implemented method, does not involve acid or base catalysts in the synthesis process, and is also environmentally friendly. It is a synthesis method for producing N-benzyl-2-(2-nitro-1-H-imidazol-1-yl)acetamide from the N-benzyl-2-hydroxyacetamide and 2-nitro-1H-imidazol reaction mixture, using microwave irradiation as an activation source in order to produce the N-benzyl-2-(2-nitro-1H-imidazol-1-yl)acetamide.
    Type: Grant
    Filed: November 19, 2014
    Date of Patent: September 19, 2017
    Assignee: Ministerio De Educacion
    Inventors: Erlinda Hándal Vega, Carmen Elena Arias Rivas, Ana Karina Cuchilla De Merlos
  • Publication number: 20160289197
    Abstract: The invention relates to the synthesis of a therapeutic agent which is effective against American trypanosomiasis (Chagas disease) caused by the protozoa Tripanosoma cruzi and transmitted by blood-sucking insects of the genera Triatoma or Rhodnius. This synthesis method is carried out in one step, in a solid state. It is a clean, simple, economical, rapid, easily implemented method, does not involve acid or base catalysts in the synthesis process, and is also environmentally friendly. It is a synthesis method for producing N-benzyl-2-(2-nitro-1-H-imidazol-1-yl)acetamide from the N-benzyl-2-hydroxyacetamide and 2-nitro-1H-imidazol reaction mixture, using microwave irradiation as an activation source in order to produce the N-benzyl-2-(2-nitro-1H-imidazol-1-yl)acetamide.
    Type: Application
    Filed: November 19, 2014
    Publication date: October 6, 2016
    Applicant: MINISTERIO DE EDUCACIÓN
    Inventors: Erlinda HÁNDAL VEGA, Carmen Elena ARIAS RIVAS, Ana Karina CUCHILLA DE MERLOS